Skip to main content

Skadden, Arps, Slate, Meagher & Flom has advised Yixin Group, China’s largest online car retailer, on its $867 million initial public offering in Hong Kong, with Freshfields Bruckhaus Deringer acting as legal adviser to the joint sponsors and underwriters.

Chinese firms Han Kun Law Offices and Jingtian & Gongcheng were also involved, acting as advisers on PRC law to Yixin and the joint sponsors and underwriters, respectively. Offshore firm Maples and Calder counseled Yixin on Cayman Islands law.

Yixin, which his backed by Chinese internet giants Tencent, JD.com and Baidu, gained as much as 32 percent on its trading debut on Thursday, benefiting from rising enthusiasm for technology stocks in the Asian financial hub, reported Reuters.

Yixin’s debut is the latest in a string of technology share offerings in Hong Kong, which have been generating strong retail investor demand.

On Monday, Razer surged 18 percent in its Hong Kong stock market debut, after raising about $500 million in an IPO, and last week, China Literature the e-book unit of Tencent, saw its shares surge more than 80 percent in its debut, marking the biggest first-day gain for a large IPO globally this year.

The Skadden team included partners Julie Gao, Christopher Betts and Will Cai in Hong Kong, as well as Haiping Li in Shanghai.

Hong Kong-based partners Grace Huang and Calvin Lai led the deal for Freshfields.

Related Articles

Cleary, A&O Shearman advise on Goodyear's $701 mln Dunlop sale

Cleary Gottlieb has advised tyremaker Goodyear Tire & Rubber Company on the $701 million sale of its Dunlop brand to Japan's Sumitomo Rubber Industries (SRI), which was represented by A&O Shearman.

Mori Hamada, Nagashima Ohno advise on $1.6 bln bid for Fujitsu General

Japanese law firms Mori Hamada & Matsumoto and Nagashima Ohno & Tsunematsu are playing key roles in Paloma Rheem Holdings' 257 billion yen ($1.6 billion) offer to acquire air conditioner manufacturer Fujitsu General.

CAM, Khaitan, Linklaters act on $355 mln Sai Life Sciences IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas has driven the $355 million initial public offering of TPG-backed Indian healthcare R&D firm Sai Life Sciences, with Khaitan & Co and Linklaters advising the bookrunning lead managers. CAM has also acted for selling promoter shareholders Sai Quest Syn.